Emmanuel Huynh
Voorzitter bij ABIONYX PHARMA
Profiel
Emmanuel Huynh is the founder of H4 Orphan Pharma SAS, which was founded in 2016.
He is also the founder of Newcap SASU and Newcap SAS.
Dr. Huynh's current job positions include Chairman at ABIONYX Pharma SA, Chairman at Domundi SC, and Director & Vice President at Alfred Fournier Institute.
Dr. Huynh's education history includes an MBA from Sciences Po and a doctorate from Sorbonne Université.
Actieve functies van Emmanuel Huynh
| Bedrijven | Functie | Begin |
|---|---|---|
| ABIONYX PHARMA | Voorzitter | 12-09-2019 |
Newcap SASU
 Newcap SASU Miscellaneous Commercial ServicesCommercial Services Newcap SAS provides investor relations and strategic communication advisory services. It specializes in financial advertising, analyst relations, sectoral communication, media relations, institutional communication, initial public offering, and international market intelligence. The company was founded by Emmanuel Huynh and Pierre Laurent and is headquartered in Paris, France. | Algemeen Directeur | - |
| Domundi SC | Voorzitter | - |
Alfred Fournier Institute
 Alfred Fournier Institute Medical/Nursing ServicesHealth Services Alfred Fournier Institute operates a medical center. The private company is based in Paris, France. | Directeur/Bestuurslid | - |
Newcap SAS
 Newcap SAS Financial ConglomeratesFinance Newcap SAS is a specialist in investor relations and strategic communication consulting. Newcap is based in Paris, FR and was founded by Pierre Laurent and Emmanuel Huynh. The French company advises and supports its clients in their sector-based, scientific, institutional, and financial communication strategy. | Oprichter | - |
H4 Orphan Pharma SAS
 H4 Orphan Pharma SAS Pharmaceuticals: MajorHealth Technology H4 Orphan Pharma SAS engages in the development of pharmaceutical products for orphan diseases. It specializes in treatments for pulmonary idiopathic fibrosis, severe asthma, and chronic obstructive pulmonary disease. The company was founded on June 21, 2016 and is headquartered in Dijon, France. | Oprichter | 01-01-2016 |
Opleiding van Emmanuel Huynh
| Sciences Po | Masters Business Admin |
| Sorbonne Université | Doctorate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| ABIONYX PHARMA | Health Technology |
| Bedrijven in privébezit | 5 |
|---|---|
Newcap SASU
Newcap SASU Miscellaneous Commercial ServicesCommercial Services Newcap SAS provides investor relations and strategic communication advisory services. It specializes in financial advertising, analyst relations, sectoral communication, media relations, institutional communication, initial public offering, and international market intelligence. The company was founded by Emmanuel Huynh and Pierre Laurent and is headquartered in Paris, France. | Commercial Services |
Alfred Fournier Institute
Alfred Fournier Institute Medical/Nursing ServicesHealth Services Alfred Fournier Institute operates a medical center. The private company is based in Paris, France. | Health Services |
Newcap SAS
Newcap SAS Financial ConglomeratesFinance Newcap SAS is a specialist in investor relations and strategic communication consulting. Newcap is based in Paris, FR and was founded by Pierre Laurent and Emmanuel Huynh. The French company advises and supports its clients in their sector-based, scientific, institutional, and financial communication strategy. | Finance |
H4 Orphan Pharma SAS
H4 Orphan Pharma SAS Pharmaceuticals: MajorHealth Technology H4 Orphan Pharma SAS engages in the development of pharmaceutical products for orphan diseases. It specializes in treatments for pulmonary idiopathic fibrosis, severe asthma, and chronic obstructive pulmonary disease. The company was founded on June 21, 2016 and is headquartered in Dijon, France. | Health Technology |
| Domundi SC |
